Astel­las an­nu­al can­cer prize goes to mo­bile re­port­ing app to bridge care gaps

3 years ago
Pharma
Marketing

Eli Lil­ly plucks a new com­mer­cial chief from Bris­tol My­ers in man­age­ment shuf­fle as HR chief re­tires

3 years ago
People
Pharma

Man­u­fac­tur­ing roundup: Mil­li­pore­Sig­ma launch­es new AAV plat­form; New IV flu­id man­u­fac­tur­ing fa­cil­i­ty is com­ing to ...

3 years ago
Manufacturing

FDA rais­es ques­tions with Eu­ro­pean da­ta law's re­stric­tions on re­view­ing clin­i­cal da­ta

3 years ago
Pharma
FDA+

Graphite Bio be­gins SCD cell ther­a­py tri­al; Syn­thet­ic Bi­o­log­ic­s' fu­ture rests on VCN ac­qui­si­tion

3 years ago
News Briefing

Sim­ba Gill heads back to Flag­ship af­ter sev­en-year run as Evelo CEO

3 years ago
People

Just months af­ter lay­offs and push­ing eye ther­a­py, Pro­QR to of­fload eye port­fo­lio in piv­ot to RNA-edit­ing

3 years ago
R&D

Fol­low­ing the re­cent play­book, Cin­Cor rais­es $225M on back of pos­i­tive PhII read­out

3 years ago
Financing
R&D

Ad­vent to sell stake in man­u­fac­tur­er and drug de­vel­op­er in a deal worth over $1B — re­port

3 years ago
Deals
Manufacturing

De­mand-con­strained Covid vac­cine mar­ket may push South Africa's As­pen to change its di­rec­tion

3 years ago
Coronavirus
Manufacturing

Amid Roche and Sanofi's oral SERD set­backs, Menar­i­ni gets speedy re­view at FDA

3 years ago
Pharma
FDA+

Cit­ing 'chal­leng­ing eco­nom­ic en­vi­ron­ment,' PhI­II-ready mi­cro­bio­me biotech lays off 20% of staffers

3 years ago
People

Cerev­el takes the pub­lic of­fer­ing route, with a twist — rais­ing big mon­ey thanks to ri­val da­ta

3 years ago
Financing

One year in­to clin­i­cal hold, FDA has more ques­tions about 'pooled' mi­cro­bio­me ther­a­py

3 years ago
FDA+

Pfiz­er launch­es re­bate pro­gram for rare dis­ease pa­tients who have to stop tak­ing Panzy­ga

3 years ago
Pharma

Hori­zon read­ies kids and fam­i­lies for back to school with week­long ac­tiv­i­ties around rare dis­ease cysti­nosis

3 years ago
Pharma
Marketing

EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

3 years ago
Pharma
Manufacturing

Ma­jor drug price re­forms head for Biden's sig­na­ture as PhRMA weighs le­gal op­tions

3 years ago
Pharma
Law

Catal­ent ac­quires North Car­oli­na CD­MO for $475M, boost­ing oral solids work

3 years ago
Deals
Manufacturing

Phar­mas spend mil­lions on di­a­betes ad­ver­tis­ing, but few pa­tients can re­call brand names — sur­vey

3 years ago
Pharma
Marketing

Faced with thou­sands of opi­oid law­suits, En­do says it will like­ly file for bank­rupt­cy 'im­mi­nent­ly'

3 years ago
Pharma
Law

Bris­tol My­ers flash­es a thumbs-up on piv­otal push to ex­pand Abec­ma's BC­MA CAR-T mar­ket

3 years ago
Pharma
Cell/Gene Tx

Pen­ny stock biotech miss­es on its sole clin­i­cal tri­al; Cal­adrius teams up with Roche for pan­cre­at­ic can­cer ...

3 years ago
News Briefing

Af­ter FDA re­vokes EUA for GSK-part­nered mAb, Vir changes its plans on Covid-19 treat­ments

3 years ago
R&D
Coronavirus
First page Previous page 475476477478479480481 Next page Last page
A service from the Financial Times